TCM
DXCM icon

TimesSquare Capital Management’s DexCom DXCM Stock Holding History

TimesSquare Capital Management’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-697,265
Closed -$46.7M – 159
2024
Q3 		$46.7M Sell
697,265
-7,215
-1% -$592K 0.7% 55
2024
Q2 		$79.9M Sell
704,480
-10,200
-1% -$1.29M 1.26% 23
2024
Q1 		$99.1M Sell
714,680
-53,910
-7% -$6.78M 1.44% 13
2023
Q4 		$95.4M Buy
768,590
+35,210
+5% +$3.6M 1.4% 15
2023
Q3 		$68.4M Buy
733,380
+726,980
+11,359% +$81.9M 1.07% 25
2023
Q2 		$822K Sell
6,400
-200
-3% -$24.2K 0.01% 169
2023
Q1 		$767K Buy
6,600
+300
+5% +$33.6K 0.01% 173
2022
Q4 		$713K Sell
6,300
-1,700
-21% -$187K 0.01% 174
2022
Q3 		$644K Buy
+8,000
New +$678K 0.01% 186
2019
Q2 		– Sell
-967,200
Closed -$28.8M – 227
2019
Q1 		$28.8M Sell
967,200
-947,200
-49% -$33.3M 0.22% 155
2018
Q4 		$57.3M Buy
1,914,400
+59,600
+3% +$1.89M 0.49% 85
2018
Q3 		$66.3M Buy
+1,854,800
New +$57.5M 0.44% 88

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

TimesSquare Capital Management's DXCM Position: Q4 2024 in Review

TimesSquare Capital Management sold out of DexCom (DXCM) in Q4 2024, closing a stake of 697,265 shares — an estimated $46.7M sold.

TimesSquare Capital Management first reported a position in DXCM in Q3 2018 and held it in 12 quarters. The position peaked at $99.1M in Q1 2024. 952 funds tracked by Wall St. Rank hold DXCM as of Q4 2024.

  • TimesSquare Capital Management reported no remaining DexCom position as of Q4 2024 after selling out during the quarter.
  • TimesSquare Capital Management sold 697,265 DexCom shares in Q4 2024, an estimated $46.7M.
  • TimesSquare Capital Management first reported a position in DexCom in Q3 2018 and held it in 12 quarters.
  • TimesSquare Capital Management's DexCom position peaked at $99.1M in Q1 2024.
  • 952 funds tracked by Wall St. Rank held DexCom as of Q4 2024.

Based on TimesSquare Capital Management's 13F filing for Q4 2024, filed 3 Feb 2025.